Full text
PDFPage 445
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Feldman A. M., Bristow M. R., Parmley W. W., Carson P. E., Pepine C. J., Gilbert E. M., Strobeck J. E., Hendrix G. H., Powers E. R., Bain R. P. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med. 1993 Jul 15;329(3):149–155. doi: 10.1056/NEJM199307153290301. [DOI] [PubMed] [Google Scholar]
- George W. J., Polson J. B., O'Toole A. G., Goldberg N. D. Elevation of guanosine 3',5'-cyclic phosphate in rat heart after perfusion with acetylcholine. Proc Natl Acad Sci U S A. 1970 Jun;66(2):398–403. doi: 10.1073/pnas.66.2.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Han X., Shimoni Y., Giles W. R. An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J Physiol. 1994 Apr 15;476(2):309–314. doi: 10.1113/jphysiol.1994.sp020132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirstein M., Rivet-Bastide M., Hatem S., Bénardeau A., Mercadier J. J., Fischmeister R. Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest. 1995 Feb;95(2):794–802. doi: 10.1172/JCI117729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McDonald T. F., Pelzer S., Trautwein W., Pelzer D. J. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev. 1994 Apr;74(2):365–507. doi: 10.1152/physrev.1994.74.2.365. [DOI] [PubMed] [Google Scholar]
- Méry P. F., Lohmann S. M., Walter U., Fischmeister R. Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1197–1201. doi: 10.1073/pnas.88.4.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Narahara K. A. Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group. Am Heart J. 1991 May;121(5):1471–1479. doi: 10.1016/0002-8703(91)90154-a. [DOI] [PubMed] [Google Scholar]
- Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
- Packer M. The development of positive inotropic agents for chronic heart failure: how have we gone astray? J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):119A–126A. doi: 10.1016/0735-1097(93)90474-f. [DOI] [PubMed] [Google Scholar]
- Walter U. Cyclic-GMP-regulated enzymes and their possible physiological functions. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;17:249–258. [PubMed] [Google Scholar]